Authors: Wiseman, GA White, CA Sparks, RB Erwin, WD Podoloff, DA Lamonica, D Bartlett, NL Parker, JA Dunn, WL Spies, SM Belanger, R Witzig, TE Leigh, BR

Citation: Ga. Wiseman et al., Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin (TM) radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, CR R ONC H, 39(1-2), 2001, pp. 181-194

Authors: Dunn, WL Yacout, AM

Citation: Wl. Dunn et Am. Yacout, Corrosion detection in aircraft by X-ray backscatter methods, APPL RAD IS, 53(4-5), 2000, pp. 625-632

Authors: Wiseman, GA White, CA Stabin, M Dunn, WL Erwin, W Dahlbom, M Raubitschek, A Karvelis, K Schultheiss, T Witzig, TE Belanger, R Spies, S Silverman, DHS Berlfein, JR Ding, E Grillo-Lopezs, AJ

Citation: Ga. Wiseman et al., Phase I/II Y-90-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma, EUR J NUCL, 27(7), 2000, pp. 766-777

Authors: Looker, AC Wahner, HW Dunn, WL Calvo, MS Harris, TB Heyse, SP Johnston, CC Lindsay, R

Citation: Ac. Looker et al., Updated data on proximal femur bone mineral levels of US adults, OSTEOPOR IN, 8(5), 1998, pp. 468-489